Status:
TERMINATED
Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients
Lead Sponsor:
Korean Medicine Hospital of Pusan National University
Collaborating Sponsors:
Pusan National University Yangsan Hospital
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims for evaluating the effectiveness, safety and feasibility of additional acupuncture therapy for lung cancer patients who are under chemotherapy in an inpatient setting. The acupuncture ...
Eligibility Criteria
Inclusion
- At least 18 years of age
- Karnofsky Performance Status (KPS) 60% or more
- Undergoing antineoplastic chemotherapy for lung cancer
- Able to provide informed consent
Exclusion
- Brain metastasis, stroke or major psychiatric diseases
- Active infection
- Severe heart disease
- Serious systemic diseases such as uncontrolled hypertension and diabetes mellitus
- Acupuncture therapy within the previous three months
- Communication disorder
- Unwillingness to participate in the trial
- Severe immunocompromised state (absolute neutrophils count \< 1000/cubic mm)
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT01408212
Start Date
July 1 2011
End Date
December 1 2012
Last Update
September 2 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pusan National University Yangsan Hospital and Korean Medicine Hospital of Pusan National University
Yangsan, Gyeongsangnam-do, South Korea, 626-770